Vaccines (Sep 2020)

Increasing Measles Seroprevalence in a Sample of Pediatric and Adolescent Population of Tuscany (Italy): A Vaccination Campaign Success

  • Beatrice Zanella,
  • Sara Boccalini,
  • Benedetta Bonito,
  • Marco Del Riccio,
  • Emilia Tiscione,
  • Paolo Bonanni,
  • Working Group DHS,
  • Working Group AOUMeyer,
  • Working Group AUSLTC,
  • Angela Bechini

DOI
https://doi.org/10.3390/vaccines8030512
Journal volume & issue
Vol. 8, no. 3
p. 512

Abstract

Read online

Background: Despite the National Plan for the Elimination of Measles and congenital Rubella (NPEMcR), in 2017, a measles outbreak occurred in Italy, due to sub-optimal vaccination coverage (Methods: The enzyme-linked immunosorbent assay (ELISA) was applied for a qualitative measurement of anti-measles antibodies on 165 sera. The anamnestic and vaccination status was also collected. Results: No measles notification was reported. The overall seropositivity was 88.5%; mostly in the 5–9 years old subjects (97.9%). Among the 152 vaccinated, 92.1% were positive. The seropositivity persisted after many years since the last dose of vaccine and tended to be more long-lasting in those who had received two or three doses. The susceptibility towards measles decreased over time, reaching a lower value in the current survey (8.5%) than in 2003 (30.8%) and in 2005–2006 (25.5%). Conclusions: This study confirmed the anti-measles vaccination campaign success, which allowed for the increase in vaccination coverage and immunity levels against measles in the Florentine pediatric and adolescent population following the NPEMcR implementation.

Keywords